Assoc Prof Dr. Jiang Pi, School of Medical Technology, Guangdong Medical University, China
Assoc. Prof. Dr. Jiang Pi appears to be a strong candidate for the Best Researcher Award based on the following qualifications:
Publication profile
Research Excellence:
Dr. Jiang Pi has made significant contributions to the fields of
biomaterials, nanotechnology, and targeted drug delivery, particularly in developing innovative therapies for tuberculosis and cancer. His work has resulted in numerous high-impact publications in leading journals, demonstrating a strong research output and expertise.
Recognition and Honors:
Dr. Jiang has been listed among the world’s top 2% scientists for three consecutive years (2021-2023). This recognition highlights his influence and contribution to his field on a global scale.
Leadership and Editorial Roles:
As Vice Dean at Guangdong Medical University, Dr. Jiang shows leadership in academia. His editorial roles in high-impact journals like Pharmacological Research, Frontiers in Pharmacology, and others reflect his active involvement and recognition in the scientific community.
Postdoctoral and Academic Training:
His extensive training, including a postdoctoral research position at the University of Illinois, Chicago, provides a solid foundation for his research.
Scientific Funding and Projects:
Dr. Jiang Pi has secured significant research funding, underscoring his capability to lead and manage research projects successfully.
Publication Top Notes
- 🦠 Roles of HIF-1α signaling in Mycobacterium tuberculosis infection: New targets for anti-TB therapeutics?
Authors: Li, C., Wang, J., Xu, J.-F., Pi, J., Zheng, B.
Source: Biochemical and Biophysical Research Communications, 2024, 711, 149920.
📚
- 🌿 Intratracheal Administration of Stem Cell Membrane-Cloaked Naringin-Loaded Biomimetic Nanoparticles Promotes Resolution of Acute Lung Injury
Authors: Jin, H., Zhao, Y., Yao, Y., Pi, J., Huang, G.
Source: Antioxidants, 2024, 13(3), 282.
📚 Cited by: 2
- 🧠 Exploring Novel Antidepressants Targeting G Protein-Coupled Receptors and Key Membrane Receptors Based on Molecular Structures
Authors: Yao, H., Wang, X., Chi, J., Pi, J., Xu, J.-F.
Source: Molecules, 2024, 29(5), 964.
📚 Cited by: 1
- 🧬 Zinc Oxide-Selenium Nanoparticles for Inhibiting the Proliferation of Porcine Reproductive and Respiratory Syndrome Virus
Authors: Xu, Y., Li, Q., Chen, Y., Zhou, L., Liu, J.
Source: ACS Applied Nano Materials, 2024, 7(4), pp. 3734–3747.
📚 Cited by: 2
- 💊 Oral delivery of pH-sensitive nanoparticles loaded Celastrol targeting the inflammatory colons to treat ulcerative colitis
Authors: Zhao, Y., Yao, Y., Fan, S., Huang, G., Jin, H.
Source: Journal of Tissue Engineering, 2024, 15.
📚
- 🦠 Identification and Validation of Genes Related to Macrophage Polarization and Cell Death Modes Under Mycobacterium tuberculosis Infection
Authors: Yang, Z., Wang, J., Pi, J., Zhao, Y., Wang, Y.
Source: Journal of Inflammation Research, 2024, 17, pp. 1397–1411.
📚
- 🦠 Macrophage targeted iron oxide nanodecoys augment innate immunological and drug killings for more effective Mycobacterium Tuberculosis clearance
Authors: Shen, L., Liao, K., Yang, E., Xu, J.-F., Pi, J.
Source: Journal of Nanobiotechnology, 2023, 21(1), 369.
📚 Cited by: 2
- 📈 Advances of Long Non-Coding RNAs as Potential Biomarkers for Tuberculosis: New Hope for Diagnosis?
Authors: Xia, J., Liu, Y., Ma, Y., Xu, J.-F., Pi, J.
Source: Pharmaceutics, 2023, 15(8), 2096.
📚 Cited by: 3
Conclusion
Dr. Jiang Pi’s profile demonstrates the qualifications, recognition, and impact necessary for consideration in the Best Researcher Award.